Caladrius Biosciences Eulerpool naujienos

Caladrius Biosciences Eulerpool News

Caladrius Biosciences akcijų naujienos

Caladrius Biosciences stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Caladrius Biosciences naujienas mes pateikiame čia.

• rugsėjo 14 d. ·

  Thefly.com
  Caladrius announces approval of merger, name change to Lisata Therapeutics
• rugsėjo 12 d. ·

  Yahoo
  Life Sciences Virtual Investor Conference Agenda Announced for September 15th
• rugsėjo 8 d. ·

  Yahoo
  Caladrius Biosciences Announces Participation in Upcoming Investor Conferences in September 2022
• rugsėjo 2 d. ·

  InvestorPlace
  Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
• rugpjūčio 10 d. ·

  Yahoo
  Caladrius Biosciences’ Prospective Merger Partner, Cend Therapeutics, Announces Collaboration Agreement with Roche to Evaluate CEND-1 in Combination with Immunotherapy to Treat Pancreatic Cancer
• rugpjūčio 10 d. ·

  TipRanks
  Analysts Conflicted on These Healthcare Names: Haemonetics (HAE), Caladrius Biosciences (CLBS) and Adicet Bio (ACET)
• rugpjūčio 10 d. ·

  Thefly.com
  Caladrius announces Cend's agreement with F. Hoffmann-La Roche
• rugpjūčio 7 d. ·

  TipRanks
  Dawson James Sticks to Its Hold Rating for Caladrius Biosciences (CLBS)
• rugpjūčio 5 d. ·

  TipRanks
  H.C. Wainwright Thinks Caladrius Biosciences’ Stock is Going to Recover
• rugpjūčio 5 d. ·

  SeekingAlpha
  Caladrius Biosciences, Inc. (CLBS) CEO David Mazzo on Q2 2022 Results - Earnings Call Transcript